BACKGROUND: Cigarette smoking is the major cause of chronic obstructive pulmonary disease, but studies on the contribution of other smoking techniques are sparse. OBJECTIVE: To determine whether pipe and cigar smoking was associated with elevated cotinine levels, decrements in lung function, and increased odds of airflow obstruction. DESIGN: Cross-sectional study. SETTING: Population-based sample from 6 U.S. communities. PARTICIPANTS: Men and women aged 48 to 90 years without clinical cardiovascular disease at enrollment who were part of MESA (Multi-Ethnic Study of Atherosclerosis). MEASUREMENTS: The MESA Lung Study measured spirometry according to American Thoracic Society guidelines and urine cotinine levels by immunoassay on a subsample of MESA. Pipe-years and cigar-years were calculated as years from self-reported age of starting to age of quitting (or to current age in current users) multiplied by pipe-bowls or cigars per day. RESULTS: Of 3528 participants, 9% reported pipe smoking (median, 15 pipe-years), 11% reported cigar smoking (median, 6 cigar-years), and 52% reported cigarette smoking (median, 18 pack-years). Self-reported current pipe and cigar smokers had elevated urine cotinine levels compared with never-smokers. Pipe-years were associated with decrements in FEV(1), and cigar-years were associated with decrements in the FEV(1)-FVC ratio. Participants who smoked pipes or cigars had increased odds of airflow obstruction whether they had also smoked cigarettes (odds ratio, 3.43 [95% CI, 1.75 to 6.71]; P < 0.001) or not (odds ratio, 2.31 [CI, 1.04 to 5.11]; P = 0.039) compared with participants with no smoking history. LIMITATION: Cross-sectional design. CONCLUSION: Pipe and cigar smoking increased urine cotinine levels and was associated with decreased lung function and increased odds of airflow obstruction, even in participants who had never smoked cigarettes. PRIMARY FUNDING SOURCE: National Heart, Lung, and Blood Institute, National Institutes of Health.
BACKGROUND: Cigarette smoking is the major cause of chronic obstructive pulmonary disease, but studies on the contribution of other smoking techniques are sparse. OBJECTIVE: To determine whether pipe and cigar smoking was associated with elevated cotinine levels, decrements in lung function, and increased odds of airflow obstruction. DESIGN: Cross-sectional study. SETTING: Population-based sample from 6 U.S. communities. PARTICIPANTS: Men and women aged 48 to 90 years without clinical cardiovascular disease at enrollment who were part of MESA (Multi-Ethnic Study of Atherosclerosis). MEASUREMENTS: The MESA Lung Study measured spirometry according to American Thoracic Society guidelines and urine cotinine levels by immunoassay on a subsample of MESA. Pipe-years and cigar-years were calculated as years from self-reported age of starting to age of quitting (or to current age in current users) multiplied by pipe-bowls or cigars per day. RESULTS: Of 3528 participants, 9% reported pipe smoking (median, 15 pipe-years), 11% reported cigar smoking (median, 6 cigar-years), and 52% reported cigarette smoking (median, 18 pack-years). Self-reported current pipe and cigar smokers had elevated urine cotinine levels compared with never-smokers. Pipe-years were associated with decrements in FEV(1), and cigar-years were associated with decrements in the FEV(1)-FVC ratio. Participants who smoked pipes or cigars had increased odds of airflow obstruction whether they had also smoked cigarettes (odds ratio, 3.43 [95% CI, 1.75 to 6.71]; P < 0.001) or not (odds ratio, 2.31 [CI, 1.04 to 5.11]; P = 0.039) compared with participants with no smoking history. LIMITATION: Cross-sectional design. CONCLUSION: Pipe and cigar smoking increased urine cotinine levels and was associated with decreased lung function and increased odds of airflow obstruction, even in participants who had never smoked cigarettes. PRIMARY FUNDING SOURCE: National Heart, Lung, and Blood Institute, National Institutes of Health.
Authors: F Baker; S R Ainsworth; J T Dye; C Crammer; M J Thun; D Hoffmann; J L Repace; J E Henningfield; J Slade; J Pinney; T Shanks; D M Burns; G N Connolly; D R Shopland Journal: JAMA Date: 2000-08-09 Impact factor: 56.272
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Surya P Bhatt; Pallavi P Balte; Joseph E Schwartz; Patricia A Cassano; David Couper; David R Jacobs; Ravi Kalhan; George T O'Connor; Sachin Yende; Jason L Sanders; Jason G Umans; Mark T Dransfield; Paulo H Chaves; Wendy B White; Elizabeth C Oelsner Journal: JAMA Date: 2019-06-25 Impact factor: 56.272
Authors: I-Chan Huang; James L Klosky; Chelsea M Young; Sharon E Murphy; Kevin K Krull; DeoKumar Srivastava; Melissa M Hudson; Leslie L Robison Journal: Pediatr Blood Cancer Date: 2018-06-01 Impact factor: 3.167
Authors: Harjit Chahal; Susan R Heckbert; R Graham Barr; David A Bluemke; Aditya Jain; Mohammadali Habibi; Alvaro Alonso; Richard Kronmal; David R Jacobs; Joao A C Lima; Karol E Watson; Kiang Liu; Lewis J Smith; Philip Greenland Journal: Am J Cardiol Date: 2015-03-24 Impact factor: 2.778
Authors: Wei Chen; John M Brehm; Ani Manichaikul; Michael H Cho; Nadia Boutaoui; Qi Yan; Kristin M Burkart; Paul L Enright; Jerome I Rotter; Hans Petersen; Shuguang Leng; Ma'en Obeidat; Yohan Bossé; Corry-Anke Brandsma; Ke Hao; Stephen S Rich; Rhea Powell; Lydiana Avila; Manuel Soto-Quiros; Edwin K Silverman; Yohannes Tesfaigzi; R Graham Barr; Juan C Celedón Journal: Ann Am Thorac Soc Date: 2015-03
Authors: Suzaynn F Schick; Benjamin C Blount; Peyton Jacob; Najat A Saliba; John T Bernert; Ahmad El Hellani; Peter Jatlow; R Steven Pappas; Lanqing Wang; Jonathan Foulds; Arunava Ghosh; Stephen S Hecht; John C Gomez; Jessica R Martin; Clementina Mesaros; Sanjay Srivastava; Gideon St Helen; Robert Tarran; Pawel K Lorkiewicz; Ian A Blair; Heather L Kimmel; Claire M Doerschuk; Neal L Benowitz; Aruni Bhatnagar Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-05-18 Impact factor: 5.464
Authors: Katja Hueper; Megha A Parikh; Martin R Prince; Christian Schoenfeld; Chia Liu; David A Bluemke; Stephen M Dashnaw; Thomas A Goldstein; Eric A Hoffman; Joao A Lima; Jan Skrok; Jie Zheng; R Graham Barr; Jens Vogel-Claussen Journal: Invest Radiol Date: 2013-04 Impact factor: 6.016
Authors: Talea Cornelius; Joseph E Schwartz; Pallavi Balte; Surya P Bhatt; Patricia A Cassano; David Currow; David R Jacobs; Miriam Johnson; Ravi Kalhan; Richard Kronmal; Laura Loehr; George T O'Connor; Benjamin Smith; Wendy B White; Sachin Yende; Elizabeth C Oelsner Journal: Am J Epidemiol Date: 2020-10-01 Impact factor: 4.897
Authors: Rhea Powell; Duncan Davidson; Jasmin Divers; Ani Manichaikul; J Jeffrey Carr; Robert Detrano; Eric A Hoffman; Rui Jiang; Richard A Kronmal; Kiang Liu; Naresh M Punjabi; Eyal Shahar; Karol E Watson; Jerome I Rotter; Kent D Taylor; Stephen S Rich; R Graham Barr Journal: Thorax Date: 2013-04-12 Impact factor: 9.139
Authors: Christian M Lo Cascio; Mirja Quante; Eric A Hoffman; Alain G Bertoni; Carrie P Aaron; Joseph E Schwartz; Mark V Avdalovic; Vincent S Fan; Gina S Lovasi; Steven M Kawut; John H M Austin; Susan Redline; R Graham Barr Journal: Chest Date: 2016-12-06 Impact factor: 9.410